Jiangsu GDK Biotechnology Co Ltd Capital Reinvestment Ratio
Jiangsu GDK Biotechnology Co Ltd capital reinvestment ratio. Jiangsu GDK Biotechnology Co Ltd (688670) has a Capital Reinvestment Ratio of 1.58x as of December 2023, meaning it reinvests 2% of its operating cash flow (CN¥22.70 Million) in capital expenditures (CN¥35.83 Million). See 688670 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jiangsu GDK Biotechnology Co Ltd (2020–2023)
Capital reinvestment ratio of Jiangsu GDK Biotechnology Co Ltd from 2020 to 2023. This chart tracks Jiangsu GDK Biotechnology Co Ltd's Capital Reinvestment Ratio across 4 annual periods. See Jiangsu GDK Biotechnology Co Ltd (688670) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Jiangsu GDK Biotechnology Co Ltd Capital Reinvestment Ratio by Year (2020–2023)
Jiangsu GDK Biotechnology Co Ltd capital reinvestment ratio by year from 2020 to 2023. For the full cash flow conversion analysis, see Jiangsu GDK Biotechnology Co Ltd (688670) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.67x | CN¥80.90 Million | CN¥54.00 Million | ▼ -84.7% |
| 2022 | 4.36x | CN¥38.60 Million | CN¥168.18 Million | ▲ +17.2% |
| 2021 | 3.72x | CN¥103.93 Million | CN¥386.39 Million | ▲ +897.2% |
| 2020 | 0.37x | CN¥109.46 Million | CN¥40.81 Million | — |